Literature DB >> 34918246

Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.

Bassel Akache1, Felicity C Stark1, Gerard Agbayani1, Tyler M Renner1, Michael J McCluskie2.   

Abstract

Adjuvants are key components of many vaccines, used to enhance the level and breadth of the immune response to a target antigen, thereby enhancing protection from the associated disease. In recent years, advances in our understanding of the innate and adaptive immune systems have allowed for the development of a number of novel adjuvants with differing mechanisms of action. Herein, we review adjuvants currently approved for human and veterinary use, describing their use and proposed mechanisms of action. In addition, we will discuss additional promising adjuvants currently undergoing preclinical and/or clinical testing.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adjuvant; Human; Immunomodulatory; Vaccine; Veterinary

Mesh:

Substances:

Year:  2022        PMID: 34918246     DOI: 10.1007/978-1-0716-1892-9_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  233 in total

1.  Aluminum compounds as vaccine adjuvants.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-07-06       Impact factor: 15.470

Review 2.  Old and new adjuvants.

Authors:  Amy S McKee; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2017-07-19       Impact factor: 7.486

Review 3.  Vaccine impact: Benefits for human health.

Authors:  Mark Doherty; Philippe Buchy; Baudouin Standaert; Carlo Giaquinto; David Prado-Cohrs
Journal:  Vaccine       Date:  2016-10-20       Impact factor: 3.641

Review 4.  Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.

Authors:  Vaia Pliaka; Zaharoula Kyriakopoulou; Panayotis Markoulatos
Journal:  Expert Rev Vaccines       Date:  2012-05       Impact factor: 5.217

Review 5.  Vaccines: from empirical development to rational design.

Authors:  Christine Rueckert; Carlos A Guzmán
Journal:  PLoS Pathog       Date:  2012-11-08       Impact factor: 6.823

6.  History of the Inoculation of the Cow-Pox: Further Observations on the Variolæ Vaccinæ, or Cow-Pox.

Authors:  Edward Jenner
Journal:  Med Phys J       Date:  1799-06

Review 7.  Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.

Authors:  Harm HogenEsch; Derek T O'Hagan; Christopher B Fox
Journal:  NPJ Vaccines       Date:  2018-10-10       Impact factor: 7.344

Review 8.  Vaccine Adjuvants: from 1920 to 2015 and Beyond.

Authors:  Alberta Di Pasquale; Scott Preiss; Fernanda Tavares Da Silva; Nathalie Garçon
Journal:  Vaccines (Basel)       Date:  2015-04-16

Review 9.  Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs.

Authors:  Nikolai Petrovsky
Journal:  Drug Saf       Date:  2015-11       Impact factor: 5.606

Review 10.  A guide to vaccinology: from basic principles to new developments.

Authors:  Andrew J Pollard; Else M Bijker
Journal:  Nat Rev Immunol       Date:  2020-12-22       Impact factor: 108.555

View more
  1 in total

1.  Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters.

Authors:  Felicity C Stark; Bassel Akache; Lise Deschatelets; Anh Tran; Matthew Stuible; Yves Durocher; Michael J McCluskie; Gerard Agbayani; Renu Dudani; Blair A Harrison; Tyler M Renner; Shawn R Makinen; Jegarubee Bavananthasivam; Diana Duque; Martin Gagne; Joseph Zimmermann; C David Zarley; Terrence R Cochrane; Martin Handfield
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.